DURANTE MANGONI, Emanuele
 Distribuzione geografica
Continente #
NA - Nord America 6.628
EU - Europa 5.990
AS - Asia 1.128
Continente sconosciuto - Info sul continente non disponibili 16
SA - Sud America 13
AF - Africa 8
OC - Oceania 7
Totale 13.790
Nazione #
US - Stati Uniti d'America 6.603
IE - Irlanda 1.938
UA - Ucraina 1.087
GB - Regno Unito 871
IT - Italia 618
SE - Svezia 482
SG - Singapore 481
CN - Cina 316
FI - Finlandia 311
DE - Germania 279
TR - Turchia 222
GR - Grecia 193
FR - Francia 131
KR - Corea 57
BE - Belgio 20
EU - Europa 16
CA - Canada 14
IN - India 14
RU - Federazione Russa 13
MX - Messico 11
MK - Macedonia 10
HK - Hong Kong 9
NL - Olanda 9
BR - Brasile 7
AU - Australia 5
ES - Italia 5
JP - Giappone 4
PH - Filippine 4
SA - Arabia Saudita 4
AR - Argentina 3
CH - Svizzera 3
CO - Colombia 3
CZ - Repubblica Ceca 3
IR - Iran 3
JO - Giordania 3
LT - Lituania 3
BG - Bulgaria 2
DK - Danimarca 2
EG - Egitto 2
ET - Etiopia 2
MY - Malesia 2
NZ - Nuova Zelanda 2
PL - Polonia 2
PT - Portogallo 2
RO - Romania 2
RS - Serbia 2
TW - Taiwan 2
AL - Albania 1
AT - Austria 1
ID - Indonesia 1
IL - Israele 1
KW - Kuwait 1
LK - Sri Lanka 1
MA - Marocco 1
NG - Nigeria 1
NP - Nepal 1
TH - Thailandia 1
TN - Tunisia 1
UZ - Uzbekistan 1
ZA - Sudafrica 1
Totale 13.790
Città #
Dublin 1.937
Jacksonville 1.671
Chandler 1.010
Santa Clara 602
Princeton 337
Singapore 281
Roxbury 275
Cambridge 207
Boardman 188
Woodbridge 171
Ann Arbor 135
Medford 135
New York 128
Wilmington 124
Ashburn 86
Mountain View 85
Des Moines 67
San Mateo 63
Beijing 62
Nanjing 50
Seoul 45
Jinan 34
Naples 34
Marano Di Napoli 32
Munich 32
Lappeenranta 31
Düsseldorf 28
Norwalk 26
Brussels 20
Bremen 18
Nanchang 17
Shenyang 17
Houston 16
Milan 16
Washington 16
Caserta 14
Venice 14
Helsinki 13
Hebei 12
Bologna 11
Kunming 11
Rome 11
Taiyuan 11
Napoli 10
Tianjin 10
Zhengzhou 10
Changsha 9
Hong Kong 9
London 9
Ningbo 9
Pune 9
Guadalupe 8
Volvera 8
Auburn Hills 7
Bari 7
Haikou 7
Los Angeles 7
Padova 7
Redwood City 7
Salò 7
Seattle 7
Athens 6
Hangzhou 6
Latisana 6
Moscow 6
Guangzhou 5
Middlebury 5
Orange 5
Pagani 5
Palermo 5
Taizhou 5
Toronto 5
Changchun 4
Fairfield 4
Ferrara 4
Groningen 4
Menlo Park 4
Quarto 4
Rocca di Capri Leone 4
Altamura 3
Amman 3
Amsterdam 3
Assago 3
Berlin 3
Brescia 3
Castellammare Di Stabia 3
Cinisello Balsamo 3
Edinburgh 3
Figline Vegliaturo 3
Frankfurt am Main 3
Lanzhou 3
Manchester 3
Montesarchio 3
Parma 3
Perugia 3
Pomigliano D'arco 3
Portici 3
Tappahannock 3
Addis Ababa 2
Atripalda 2
Totale 8.388
Nome #
Endocardite infettiva (EI) nei tossicodipendenti ( IVDU): prevalenza del coinvolgimento del cuore sinistro e cambiamenti del profilo microbiologico 174
Hepatocellular carcinoma in chronic HBV-HCV co-infection is correlated to fibrosis and disease duration 93
Endocardite Infettiva da Streptococcus bovis: risultati dello Studio Endocarditi Italiano (SEI) 81
Anti-envelope 1 and 2 immune response in chronic hepatitis C patients: Effects of hepatitis B virus co-infection and interferon treatment 76
Nocardiosi polmonare in pazienti con trapianto di cuore: casi clinici 76
Anticorpi anti-fosfolipidi nell’endocardite infettiva: possibile ruolo nel determinismo delle complicanze emboliche 76
Caratteristiche attuali dell'endocardite infettiva in Italia: risultati dello Studio Endocarditi Italiano (SEI) 72
20210 G/A prothrombin gene mutation in patients with ischemic heart disease 68
Association between surgical indications, operative risk, and clinical outcome in infective endocarditis: a prospective study from the International Collaboration on Endocarditis. 67
A case of destructive infective endocarditis 67
A case of coagulopathy of unclear definition 66
Epatopatia cronica ed endocardite infettiva: risultati dello studio endocardite italiano (SEI) 66
Yellow nail syndrome as a cause of unexplained edema 65
Differential expression of toll-like receptor mRNA in treatment non-responders and sustained virologic responders at baseline in patients with chronic hepatitis C 64
Three-phase sequential combined treatment with lamivudine and interferon in young patients with chronic hepatitis B 64
Efficacia e sicurezza della combinazione colistina-rifampicina in confronto con la colistina in monoterapia nelle infezioni gravi da Acinetobacter baumannii MDR: risultati preliminari 64
Utilità dell'esame colturale ed isto-patologico della valvola nell'endocardite infettiva 64
Celiachia silente in pazienti con epatite C: prevalenza, effetto del trattamento con alfa-interferone sull’attivazione della malattia ed evoluzione clinica 63
Treatment of pulmonary nocardiosis in heart-transplant patients: importance of susceptibility studies 62
Infective endocarditis due to high-level gentamicin and glycopeptides resistant enterococci: efficacy of the ampicillin-fluoroquinolones combination 62
Ruolo patogenetico dell'adiponectina nella steatosi associata ad epatite C 61
Factor V Leiden and glycoprotein IIIa PlA2 polymorphism in coronary thrombosis 61
Interferon-induced anti-HBE seroconversion correlates with a Th1 cytokine shift following emergence of core promoter mutations in chronic hepatitis B 60
Leukocyte interferon-alpha and ribavirin for treatment of chronic hepatitis C patients intolerant to pegylated-interferon 60
Effects of growth hormone therapy in Becker patients with dilated cardiomyopathy 60
Alterazioni istopatologiche epatiche in pazienti con cardiomiopatia dilatativa: prevalenza e correlazioni con l’etiologia della patologia cardiaca 60
Adefovir treatment for chronic hepatitis B in heart transplant recipients. 60
Factor V Leiden in patients with acute coronary syndromes 59
Association Between Valvular Surgery and Mortality Among Patients With Infective Endocarditis Complicated by Heart Failure 59
Antistaphylococcal β-Lactams versus Vancomycin for Treatment of Infective Endocarditis Due to Methicillin-Susceptible Coagulase-Negative Staphylococci: a Prospective Cohort Study from the International Collaboration on Endocarditis 59
Antibiotic treatment of infections caused by carbapenem-resistant Gram-negative bacilli: an international ESCMID cross-sectional survey among infection diseases specialists practicing in large hospitals 59
Unusually high rate of hepatic comorbidity with Streptococcus bovis endocarditis: trend or coincidence? 58
Multivalve involvement in infective endocarditis in the International Collaboration on Endocarditis prospective cohort study 58
Impact of early valve surgery on outcome of Staphylococcus aureus prosthetic valve infective endocarditis: analysis in the International Collaboration of Endocarditis-Prospective Cohort Study. 57
Alterazioni istopatologiche epatiche in pazienti con cardiomiopatia dilatativa: prevalenza e correlazioni con l’etiologia della patologia cardiaca 57
Oral presentation: Clinical characteristics and 1 year outcome of cardiac device infective endocarditis 57
Infezioni polmonari micotiche e da nocardia nel paziente cardiotrapiantato: caratteristiche cliniche e trattamento 57
Comunicazione orale: Cinetica precoce dell’HCV-RNA in pazienti con epatite cronica: correlati clinico-virologici e valore predittivo la risposta al trattamento antivirale 57
Insulin resistance and steatosis in HBV-HCV co-infected patients: Role of PNPLA3 polymorphisms and impact on liver fibrosis progression. 56
Oral presentation: Clinical features and outcome of patients with vascular prostheses infection 56
Sicurezza ed efficacia del trattamento con Peg-interferone e Ribavirina in pazienti con epatite C e cardiopatia strutturale 56
Heart failure in infective endocarditis: a report from the multicenter, prospective, observational Study on Endocarditis in Italy (SEI) 56
Severe diarrhea occurring during alpha-interferon treatment for chronic hepatitis C is associated with serologic markers of celiac disease 56
Oral presentation: Treatment of Duchenne dystrophy: results of 7 years cloprednol oral administration 56
Mild chronic hepatitis C with steatosis: Which treatment? 55
A preliminary randomized study of growth hormone administration in Becker and Duchenne muscular dystrophies 55
Comunicazione orale: Association of plasma homocysteine levels with infective endocarditis. 55
Trapianto cardiaco non complicato in paziente con infezione da HIV 55
Infective endocarditis on cardiac rhythm management devices: preliminary study on the possible pathogenic role of inherited thrombophilias 55
Mutato spettro clinico della endocardite infettiva in persone tossicodipendenti 55
Growth hormone evaluation in patients with dystrophinopathic muscular dystrophy and dilated cardiomyopathy 55
Defective synthesis of granulocyte-colony stimulating factor in pegylated interferon-alpha treated chronic hepatitis C patients with declining leukocyte counts 54
Ruolo dell’asse GH/IGF-1 nella fisiopatologia e nella terapia cardiovascolare: lezioni da studi sull’animale 54
Ruolo patogenetico dell’adiponectina nella steatosi associata ad epatite C 54
Prevalence of pro-thrombotic genetic polymorphisms in infective endocarditis 54
Rhodococcus equi as a cause of Infective Endocarditis: description of 2 clinical cases 54
Inherited thrombophilia as a risk factor for infective endocarditis on cardiac rhythm management devices 54
Major embolic events in infective endocarditis are associated with a younger age 54
Growth hormone improves left ventricular loading conditions in Becker Muscular Dystrophy 54
Correlation of serum HBeAg levels and double A1762T/G1764A HBV core promoter mutation with response to interferon in patients with chronic hepatitis B 54
Short-term effective bactericidal treatment of pulmonary nocardiosis in heart-transplant patients: importance of susceptibility studies 53
Hepatic steatosis and insulin resistance are associated with serum imbalance of adiponectin/tumour necrosis factor-alpha in chronic hepatitis C patients 52
Successful control of bleeding with recombinant activated factor VII (FVIIa) after cardiac re-transplantation in a patient on aggressive antiplatelet treatment 52
Comunicazione orale: Embolia maggiore nell’endocardite infettiva: associazione con l’età e la risposta di fase acuta 52
Multinational clinical experience with high dose daptomycin for the treatment of native valve endocarditis (NVE) 52
Comunicazione orale: Experience with high-doses of daptomycin in 50 patients with infective endocarditis. 52
Comunicazione orale: Prevalenza e correlati della sindrome metabolica in soggetti cardio-trapiantati 52
CD1d-restricted non-invariant T lymphocytes in hepatitis C: a novel population of intra-hepatic lymphocytes 52
Features of infective endocarditis in persons on chronic hemodialysis. Results from the prospective, observational SEI study (Italian Study on Endocarditis) 52
Factors affecting hospital mortality in critically ill patients with multi-drug resistant Acinetobacter baumannii 52
Current trends in infective endocarditis in Italy: report on 852 cases from the multicenter, prospective SEI study 52
Inherited Hyper-Homocysteinemia as a Cause of Non-Bacterial Thrombotic Endocarditis 52
Correlates and prognostic value of the first-phase hepatitis C virus RNA kinetics during treatment 51
Right diaphragm paralysis following cardiac radiofrequency catheter ablation for inappropriate sinus tachycardia 51
Normal erythropoietin response in chronic hepatitis C patients with ribavirin-induced anaemia 51
Comunicazione orale: Hepatitis C virus core antigen serum levels during chronic infection and treatment: pathogenic implications and clinical significance 51
Infective endocarditis in intravenous drug users: prevalence of left heart involvement and changing microbiological profile 51
Correlates and prognostic value of the degree of heart failure in infective endocarditis. Results from the International Collaboration on Endocarditis Prospective Cohort Study 51
Clinical characteristics and outcome of a consecutive series of patients with vascular prosthesis infection: a single center report 51
Rapida ed accurata definizione eziologica mediante real time PCR in un grave caso di polmonite 51
Safety and efficacy of peginterferon alpha plus ribavirin in patients with chronic hepatitis C and coexisting heart disease 51
Management of Gram-negative and fungal endocarditis 50
In-hospital and 1-year mortality in patients undergoing early surgery for prosthetic valve endocarditis. 50
In-hospital death according to dementia diagnosis in acutely ill elderly patients: the REPOSI study. 50
Anticorpi anti-fosfolipidi nell’endocardite infettiva: possibile ruolo nel determinismo delle complicanze emboliche 50
Comunicazione orale: Platelet glycoprotein receptor polymorphisms in infective endocarditis: prevalence and pathophysiological significance 50
First-phase HCV-RNA kinetic during antiviral therapy for chronic hepatitis C: clinical and virological correlates and predictive value for treatment outcome 50
Embolic complications of infective endocarditis (IE): report on 709 IE episodes of the Italian Study on Endocarditis (SEI) 50
Functional significance of GP1b alpha receptor polymorphism in patients with coronary artery disease 50
Report on 509 defined cases of infectious endocarditis of the multicentric italian study (SEI) 50
Infective endocarditis (IE) in intra-venous drug users (IVDU): prevalence of left heart involvement and changing microbiologic profile 50
Microsomal triglyceride transfer protein (MTP) -493G/T gene polymorphism contributes to fat liver accumulation in HCV genotype 3 infected patients 49
Risk factors for "major" embolic events in hospitalized patients with infective endocarditis 49
A European first: Successful heart transplant in a human immunodeficiency virus-positive recipient 49
Comunicazione orale: Trapianto cardiaco non complicato in paziente con infezione da HIV 49
Major embolic events in infective endocarditis are associated with a younger age 49
Growth hormone deficiency in patients with Duchenne/Becker muscular dystrophy: association with dilated cardiomyopathy 49
Endocardite infettiva su elettrocateteri intracardiaci: studio preliminare sul possibile ruolo patogenico della trombofilia ereditaria 49
Successful outcome of aortic valve replacement in a patient with Niemann-Pick disease 49
Embolia maggiore nell’endocardite infettiva: associazione con l’età e la risposta di fase acuta 48
Totale 5.780
Categoria #
all - tutte 67.977
article - articoli 0
book - libri 0
conference - conferenze 0
curatela - curatele 0
other - altro 0
patent - brevetti 0
selected - selezionate 0
volume - volumi 0
Totale 67.977


Totale Lug Ago Sett Ott Nov Dic Gen Feb Mar Apr Mag Giu
2019/2020844 0 0 0 0 285 31 311 33 71 46 53 14
2020/20212.408 138 4 282 161 402 8 312 273 23 368 293 144
2021/20221.883 71 15 9 31 688 13 29 58 62 87 152 668
2022/20233.801 369 58 22 331 381 327 25 260 1.818 36 83 91
2023/20241.623 144 45 67 90 596 136 54 74 10 20 156 231
2024/20251.043 14 55 54 159 761 0 0 0 0 0 0 0
Totale 14.248